Infosys has announced the acquisition of a 20% stake in 4baseCare, a health tech startup for ₹8.3 crore.
This investment is part of the Infosys Innovation Fund, which aims to support startups in AI and DeepTech that align with Infosys’ vision to enhance its capabilities and co-create next-generation solutions.
This investment comes just four months after 4baseCare raised $6 million in its Series A funding round, led by Yali Capital.
“Infosys Innovation Fund seeks to partner with AI and DeepTech startups such as 4baseCare to complement its capabilities and jointly co-create next-generation solutions bringing the power of innovation to help Infosys’ clients navigate their business transformation,” Infosys said in a corporate filing.
Founded in 2018 by Hitesh Goswami and Kshitij Rishi, 4baseCare provides unique precision oncology solutions leveraging diverse genomic and clinical data. 4baseCare is engaged in the development of cutting-edge precision oncology solutions, using advanced genomics and next-gen digital health technology, to personalize patient care in oncology.
4baseCare has developed a unique set of comprehensive genomic panels that allows oncologists to choose the optimal targeted therapy for their patients.
The population-specific datasets generated by them powered by tech-driven AI and Analytics solutions have immense potential to improve cancer diagnosis, treatment, drug discovery and development across the Healthcare and Life Sciences ecosystem, improving lives.
Personalized treatment based on advanced genomic and comprehensive clinical information can enhance cancer outcomes significantly.
